⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
GOSS News
Gossamer Bio, Inc. Common Stock
Form 8-K
sec.gov
GOSS
Form 8-K
sec.gov
GOSS
Form 8-K
sec.gov
GOSS
Gossamer Bio Submits New Drug Application to U.S. FDA for Seralutinib for the Treatment of Pulmonary Arterial Hypertension
businesswire.com
GOSS
Form 8-K
sec.gov
GOSS
Gossamer Bio Appoints Greg Ciongoli to Board of Directors
businesswire.com
GOSS
Hypertension Clinical Trial Pipeline Accelerates as 100+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight
globenewswire.com
BNTX
ASO
IONS
BIIB
ALT
TEVA
TENX
UTHR
PFE
UNH
ABBV
GOSS
INSM
Form 8-K
sec.gov
GOSS
Gossamer Bio Announces Effectiveness of 1-for-80 Reverse Stock Split
businesswire.com
GOSS
Form 8-K
sec.gov
GOSS